Ali Yılmaz
- Co-authors
- Salim Başol TekinMehmet BiliciCem MiriliGüzin DemirağSemra PaydaşNalan Akgül BabacanTurgut KaçanEnver Sancakdar
- Topics
- Inflammatory Biomarkers in Disease Prognosis (13 papers)Cancer Immunotherapy and Biomarkers (3 papers)Gastric Cancer Management and Outcomes (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of Colorectal DiseaseClinical Rheumatology
- Partner nations
- Türkiye
In The Last Decade
Ali Yılmaz
21 papers receiving 342 citations
Peers
Comparison fields: 5 of 51
- Oncology 243
- Pulmonary and Respiratory Medicine 77
- Surgery 64
- Epidemiology 63
- Cancer Research 36
Countries citing papers authored by Ali Yılmaz
This map shows the geographic impact of Ali Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Yılmaz more than expected).
Fields of papers citing papers by Ali Yılmaz
This network shows the impact of papers produced by Ali Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Yılmaz. The network helps show where Ali Yılmaz may publish in the future.
Co-authorship network of co-authors of Ali Yılmaz
This figure shows the co-authorship network connecting the top 25 collaborators of Ali Yılmaz. A scholar is included among the top collaborators of Ali Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Yılmaz. Ali Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 28 | |
| 8 | 8 | |
| 9 | 36 | |
| 10 | 0 | |
| 11 | 12 | |
| 12 | 31 | |
| 13 | 8 | |
| 14 | 80 | |
| 15 | 30 | |
| 16 | 1 | |
| 17 | 36 | |
| 18 | 5 | |
| 19 | 12 | |
| 20 | Duodenal stromal tumor: a rare and overlooked cause of massive gastrointestinal bleeding. | 1 |
About Ali Yılmaz
Ali Yılmaz is a scholar working on Oncology, Nephrology and Gastroenterology, having authored 25 papers that have together received 347 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (243 citations), Nephrology (24 citations) and Otorhinolaryngology (14 citations). Ali Yılmaz has collaborated with scholars based in Türkiye. Frequent co-authors include Salim Başol Tekin, Mehmet Bilici, Cem Mirili, Güzin Demirağ, Semra Paydaş, Nalan Akgül Babacan, Turgut Kaçan, Enver Sancakdar, Köksal Deveci and Mehmet Şeker. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Colorectal Disease and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.